The U.S. Embassy in Dakar has provided updated information regarding COVID-19 measures affecting travelers to and from Guinea-Bissau. As of June 12, the CDC has lifted its requirement for passengers traveling to the United States to present a negative COVID-19 test result or proof of recovery before boarding flights from foreign countries. However, non-U.S. citizen nonimmigrants are still required to show proof of vaccination.
In Guinea-Bissau, PCR and antigen tests are available for U.S. citizens, with results typically ready within one day. Testing for travel purposes is conducted at specific locations such as Liceu Agostinho Neto and Sede da Uniao Deportive Internacional for a fee of 30,000 CFA. Test scheduling and results can be accessed online through a non-English website.
The government of Guinea-Bissau has approved the AstraZeneca vaccine, which is available to U.S. citizens meeting eligibility criteria set by local authorities. The first phase of the vaccination campaign prioritizes healthcare workers, individuals with certain comorbidities, adults over 50, and those at higher risk due to their employment.
U.S. citizens are allowed entry into Guinea-Bissau without needing a negative COVID-19 test if they have been fully vaccinated at least four weeks prior to arrival. Those unvaccinated must present a recent PCR test or a certificate of recovery from COVID-19 upon entry. Health screenings are mandatory at airports and other entry points.
There are no curfews or restrictions on intercity travel within Guinea-Bissau, nor is quarantine required for U.S. citizens unless they exhibit symptoms suggestive of COVID-19 upon arrival.
Commercial flights and public transportation continue to operate in the country, but fines ranging from 50,000 to 2 million CFA may be imposed for failing to comply with health regulations.
Due to the absence of a U.S. Embassy in Guinea-Bissau, consular services remain limited for American citizens in need of emergency assistance.
Authorities in Guinea-Bissau have reinforced measures similar to those used during the Ebola outbreak between 2014 and 2016 in West Africa.
For further information on travel advisories and updates related to COVID-19 protocols, travelers can refer to official resources such as the CDC's page on COVID-19 or the travel.state.gov website.